FOLFIRI Versus Docetaxel and Cisplatin as a Second-line Chemotherapy After Failure of First-line Chemotherapy in Advanced Gastric Cancer

NCT03067792 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
52
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Yonsei University